↓ Skip to main content

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Overview of attention for article published in BMC Pulmonary Medicine, February 2014
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
Published in
BMC Pulmonary Medicine, February 2014
DOI 10.1186/1471-2466-14-21
Pubmed ID
Authors

Emily DiMango, Patricia Walker, Claire Keating, Maria Berdella, Newell Robinson, Elinor Langfelder-Schwind, Diane Levy, Xinhua Liu

Abstract

Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 17%
Student > Master 7 15%
Researcher 6 13%
Other 4 9%
Professor > Associate Professor 3 6%
Other 7 15%
Unknown 12 26%
Readers by discipline Count As %
Medicine and Dentistry 22 47%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Agricultural and Biological Sciences 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 4 9%
Unknown 13 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2014.
All research outputs
#19,819,661
of 24,356,663 outputs
Outputs from BMC Pulmonary Medicine
#1,564
of 2,107 outputs
Outputs of similar age
#262,075
of 346,747 outputs
Outputs of similar age from BMC Pulmonary Medicine
#32
of 35 outputs
Altmetric has tracked 24,356,663 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,107 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,747 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.